Thrombolytic therapy for venous thromboembolism. Complications and contraindications.
Thrombolytic therapy for venous thromboembolism. Complications and contraindications.
复制标题
静脉血栓栓塞的溶栓治疗。
作者：
M. Levine
由于溶栓治疗可降低急性心肌梗死患者的死亡率，以及新型纤维蛋白特异性药物的开发，因此对急性深静脉血栓形成和急性肺栓塞的治疗重新引起了人们的兴趣。出血是溶栓治疗的主要并发症。本文讨论了急性深静脉血栓形成或急性肺栓塞患者使用溶栓治疗的获益和风险。
There is renewed interest in the treatment of acute deep vein thrombosis and acute pulmonary embolism with thromboembolytic therapy because of the demonstrated mortality reduction in patients with acute myocardial of the demonstrated mortality reduction in patients with acute myocardial infarction and because of the development of newer, fibrin-specific drugs. Bleeding is the major complication of thrombolytic therapy. This article addresses the benefits and risks of using thrombolytic therapy in patients with acute deep vein thrombosis or acute pulmonary embolism.